Related Experiment Video
Updated: Jan 8, 2026

10:12
Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
Published on: May 15, 2018
9.4K
Successful optical genome mapping from 500 000 cells: A low-input UHMW DNA extraction approach
Elly De Vlieghere1, Friedel Nollet1, Helena Devos1
1Department of Laboratory Medicine, AZ Sint-Jan Brugge, Bruges, Belgium.
Methodsx
|December 24, 2025
Summary
This study presents a new protocol for isolating ultra-high molecular weight genomic DNA (UHMW gDNA) from fewer cells. This advance enables Optical Genome Mapping (OGM) for patients with hematological malignancies, even with limited sample availability.
Area of Science:
- Genomics
- Molecular Biology
- Clinical Diagnostics
Background:
- Optical Genome Mapping (OGM) is crucial for detecting DNA variations in hematological malignancies.
- Isolating ultra-high molecular weight genomic DNA (UHMW gDNA) for OGM typically requires 1.5 million cells.
- Clinical samples, like those from multiple myeloma patients, often have fewer than the required cells.
Purpose of the Study:
- To develop a customized protocol for isolating UHMW gDNA from a reduced cell input.
- To enable OGM analysis from limited clinical samples, such as CD138-positive cells from bone marrow aspirates.
- To ensure sufficient DNA quality and quantity for comprehensive OGM data generation.
Main Methods:
- A modified protocol was developed for UHMW gDNA isolation.
- The protocol was optimized for starting with as few as 500,000 cells.
- DNA quality and quantity were assessed for downstream OGM analysis.
Main Results:
- Successful isolation of UHMW gDNA from 500,000 cells was achieved.
- The isolated DNA was of sufficient quality and quantity for OGM.
- At least 1500 Gbp of OGM data could be collected from the prepared DNA.
Conclusions:
- The developed protocol significantly reduces the cell input requirement for UHMW gDNA isolation.
- This method expands the applicability of OGM in clinical settings, particularly for samples with limited cell numbers.
- The protocol facilitates advanced genomic analysis for hematological malignancies, improving diagnostic capabilities.

